Skip to main content
Caplight Logo









Bialtec

Bialtec

Private
DelftHealthcare & Life Scienceshttps://bialtec.co/en/home

Last Round

Grant

Nov 7, 2024

Total Funding Raised

$864,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bialtec operates in Healthcare & Life Sciences and is based in Delft. Its latest recorded funding round was a Grant round in November 2024.

Bialtec is a biotechnology company that develops and produces microencapsulated precision microbiomes for animal feed to improve gut health and nutrient absorption.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Bialtec Comparables

Compare Bialtec with similar companies based on industry and business-model similarity.

Bialtec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Native Microbials
81%
BiomEdit
78%
Mitsui & Co.
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Bialtec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 7, 2024
AcceleratorMay 16, 2022
SeedJun 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Bialtec Investors

Notable investors and investment history

Bialtec investors
InvestorRounds
Fundación Sofía Pérez de SotoSeed
RootCampAccelerator
Grow NYGrant
Taurus CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 67% MoM, from 602 to 1K.

  • Jan 21, 2026

    Monthly visitors grew 36% MoM, from 716 to 975.

Book a demo to see all signals

For institutional investors. Book with your work email.

Bialtec Filings

Explore SEC and related filing metadata, where available.

Bialtec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Bialtec's valuation, stock price, and market status.

Is Bialtec a public or private company?

Bialtec is a private company.

What is the current stock price of Bialtec?

Bialtec is a private company, so its shares have no public market price. Caplight tracks Bialtec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Bialtec worth (valuation)?

Valuation information for Bialtec is not publicly available.

Can I buy Bialtec stock?

Bialtec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Bialtec's last funding round?

Bialtec's most recent funding round was Grant on November 7, 2024.

Who are the main investors in Bialtec?

Key investors in Bialtec include Fundación Sofía Pérez de Soto, RootCamp, Grow NY, Taurus Capital.

Will Bialtec IPO soon?

No public IPO plans have been announced for Bialtec.

How can I track Bialtec secondary market activity?

Caplight tracks bids, offers, and trades in Bialtec's shares on secondary markets.

Firmographic Details

HeadquartersDelft
Employee Range21
Year Founded2011
Last FundingNov 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?